Inventor
LUKE GEORGE P
US25 patents
⚠️ This page may combine multiple inventors who share the name “LUKE GEORGE P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FORMA THERAPEUTICS INC
15 patentsUS10532047B2Jan 14, 2020
Solid forms of ((S)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile
FORMA THERAPEUTICS INC12 citations94
US10336722B2Jul 2, 2019
Tetrahydroquinoline compositions as BET bromodomain inhibitors
FORMA THERAPEUTICS INC22 citations93
US9422281B2Aug 23, 2016
Benzopiperazine compositions as BET bromodomain inhibitors
FORMA THERAPEUTICS INC25 citations93
US9388161B2Jul 12, 2016
Tetrahydroquinoline compositions as BET bromodomain inhibitors
FORMA THERAPEUTICS INC34 citations93
US11111229B2Sep 7, 2021
Tetrahydroquinoline compositions as BET bromodomain inhibitors
FORMA THERAPEUTICS INC4 citations83
US10611750B2Apr 7, 2020
Tetrahydroquinoline compositions as bet bromodomain inhibitors
FORMA THERAPEUTICS INC7 citations83
US10377769B2Aug 13, 2019
Benzopiperazine compositions as BET bromodomain inhibitors
FORMA THERAPEUTICS INC10 citations83
US10959994B2Mar 30, 2021
Solid forms of ((S)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile
FORMA THERAPEUTICS INC4 citations82
US10703764B2Jul 7, 2020
Benzopiperazine compositions as BET bromodomain inhibitors
FORMA THERAPEUTICS INC2 citations72
US11084831B1Aug 10, 2021
Benzopiperazine compositions as BET bromodomain inhibitors
FORMA THERAPEUTICS INC0 citations62
US12053463B2Aug 6, 2024
Solid forms of ((s)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile
FORMA THERAPEUTICS INC0 citations61
US11723905B2Aug 15, 2023
Solid forms of ((s)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile
FORMA THERAPEUTICS INC0 citations61
US11267805B2Mar 8, 2022
Solid forms of (4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl) piperazine-1-yl)(1-hydroxycyclopropyl)methanone
FORMA THERAPEUTICS INC0 citations59
US11566013B1Jan 31, 2023
Inhibiting mutant isocitrate dehydrogenase 1 (mIDH1)
FORMA THERAPEUTICS INC1 citations58
US10793554B2Oct 6, 2020
Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone
FORMA THERAPEUTICS INC0 citations48
NEUROGEN CORP
4 patentsUS7642267B2Jan 5, 2010
Benzimidazole and pyridylimidazole derivatives
NEUROGEN CORP20 citations92
US7253168B2Aug 7, 2007
Substituted 1-benzyl-4-substituted piperazine analogues
NEUROGEN CORP13 citations82
US6916827B2Jul 12, 2005
Substituted ring-fused imidazole derivative: GABAA receptors ligands
NEUROGEN CORP2 citations62
US7300945B2Nov 27, 2007
Benzimidazole and pyridylimidazole derivatives
NEUROGEN CORP0 citations51